{"cik":1853921,"taxonomy":"us-gaap","tag":"OperatingIncomeLoss","label":"Operating Income (Loss)","description":"The net result for the period of deducting operating expenses from operating revenues.","entityName":"SCRIBE THERAPEUTICS INC.","units":{"USD":[{"start":"2025-01-01","end":"2025-06-30","val":-17185000,"accn":"0001193125-26-380191","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-09-02"},{"start":"2025-04-01","end":"2025-06-30","val":-11627000,"accn":"0001193125-26-380191","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-09-02","frame":"CY2025Q2"},{"start":"2026-01-01","end":"2026-06-30","val":-21821000,"accn":"0001193125-26-380191","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-09-02"},{"start":"2026-04-01","end":"2026-06-30","val":-9395000,"accn":"0001193125-26-380191","fy":2026,"fp":"Q2","form":"10-Q","filed":"2026-09-02","frame":"CY2026Q2"}]}}